Swiss National Bank - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$9,983,000
+115.3%
146,600
+1.0%
0.01%
+133.3%
Q2 2022$4,636,000
-2.4%
145,100
+5.8%
0.00%0.0%
Q1 2022$4,749,000
+31.6%
137,100
+11.2%
0.00%
+50.0%
Q4 2021$3,609,000
+14.9%
123,3000.0%0.00%0.0%
Q3 2021$3,142,000
-27.2%
123,3000.0%0.00%
-33.3%
Q2 2021$4,318,000
-16.6%
123,300
-3.0%
0.00%0.0%
Q1 2021$5,179,000
-4.3%
127,100
+1.8%
0.00%
-25.0%
Q4 2020$5,409,000
-21.1%
124,900
+0.5%
0.00%
-20.0%
Q3 2020$6,854,000
-11.1%
124,300
+1.7%
0.01%
-28.6%
Q2 2020$7,714,000
+29.3%
122,200
+4.6%
0.01%
+16.7%
Q1 2020$5,967,000
-34.6%
116,800
+1.8%
0.01%
-33.3%
Q4 2019$9,118,000
+76.9%
114,700
+8.0%
0.01%
+80.0%
Q3 2019$5,153,000
-6.5%
106,200
+1.3%
0.01%
-16.7%
Q2 2019$5,512,000
+15.2%
104,800
+15.9%
0.01%
+20.0%
Q1 2019$4,785,000
+33.4%
90,400
+3.4%
0.01%0.0%
Q4 2018$3,588,000
+9.9%
87,400
+1.7%
0.01%
+25.0%
Q3 2018$3,264,000
-8.6%
85,900
+8.7%
0.00%0.0%
Q2 2018$3,571,000
-3.5%
79,000
+3.1%
0.00%
-20.0%
Q1 2018$3,700,000
+27.6%
76,600
+3.9%
0.01%
+66.7%
Q4 2017$2,900,000
+70.8%
73,700
+34.7%
0.00%
+50.0%
Q3 2017$1,698,000
+18.5%
54,700
+4.4%
0.00%0.0%
Q2 2017$1,433,000
-25.8%
52,4000.0%0.00%0.0%
Q1 2017$1,931,000
+296.5%
52,400
+55.5%
0.00%
+100.0%
Q4 2016$487,000
-24.8%
33,700
+19.9%
0.00%0.0%
Q3 2016$648,000
+39.1%
28,1000.0%0.00%0.0%
Q2 2016$466,000
+145.3%
28,100
+124.8%
0.00%
Q1 2016$190,000
-38.7%
12,500
+30.2%
0.00%
-100.0%
Q4 2015$310,0009,6000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2018
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders